**Phase 2 Clinical Trials**
==========================

### Core Concept
Phase 2 clinical trials are a type of clinical research that aims to evaluate the efficacy and side effects of a new treatment or drug in a larger group of patients. These trials usually involve 20-300 participants and are conducted after the initial safety and pharmacokinetic assessment in phase 1 trials.

### Why the Correct Answer is Right
In phase 2 trials, the primary objective is to assess the therapeutic efficacy of the investigational drug, often in patients with a specific disease or condition. This phase typically involves dose-finding studies to determine the optimal dose and dosing regimen for the treatment. The trial design may include multiple arms to evaluate different dosing strategies or compare the investigational drug to a control treatment. The data collected during phase 2 trials help to identify potential therapeutic benefits, side effects, and optimal dosing regimens for further testing in phase 3 trials.

### Why Each Wrong Option is Incorrect
**Option A:** Phase 2 trials are not primarily focused on assessing the safety of the investigational drug, which is the main goal of phase 1 trials.

**Option B:** While phase 2 trials may involve a larger number of participants, they do not typically involve thousands of patients, which is more characteristic of phase 3 trials.

**Option C:** Phase 2 trials are not primarily focused on comparing the investigational drug to multiple control treatments, although this may be a component of some trial designs.

### Clinical Pearl / High-Yield Fact
It's essential to remember that phase 2 trials are a critical step in the drug development process, as they help to identify potential therapeutic benefits and side effects, which inform the design of subsequent phase 3 trials and ultimately, regulatory approval.

### Correct Answer: D.